Coating agent for inducing differentiation of pluripotent stem cells into brain microvascular endothelium-like cells and use thereof
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for inducing differentiation of pluripotent stem cells into brain microvascular endothelium-like cells using Matrigel face reproducibility issues due to temperature-dependent solidification and variability in differentiation efficiency caused by manufacturer and production lot differences.
Innovation Solution
A coating agent containing Laminin-221 fragment or N-terminal Vitronectin is used to stabilize the differentiation process, ensuring consistent and efficient production of brain microvascular endothelium-like cells by suppressing variations in differentiation efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Matrigel is used as a coating agent for inducing differentiation of pluripotent stem cells into brain microvascular endothelium-like cells, then the cells can be cultured and differentiated, but reproducibility decreases due to temperature-dependent solidification and manufacturer/lot variations
Solution Approach 1:
The invention extracts and identifies the critical functional components of Matrigel (laminin-111, collagen-IV, entactin/nidogen) and tests them individually. By isolating specific components like laminin-221 fragment and N-terminal vitronectin, the patent eliminates the complexity and variability of using whole Matrigel while maintaining the essential coating function needed for cell differentiation.
Solution Approach 2:
The invention changes the chemical composition parameters of the coating agent from a complex mixture (Matrigel) to purified specific proteins (laminin-221 fragment, N-terminal vitronectin). This parameter change eliminates temperature-dependent solidification issues and manufacturer/lot variations while preserving the biological function of promoting endothelial cell differentiation.
2Productivity
If Matrigel is used as a coating agent, then cell differentiation can proceed, but differentiation efficiency varies due to manufacturer and production lot differences
Solution Approach 1:
The patent extracts the essential coating function from Matrigel by identifying and testing individual components. By focusing on specific proteins (laminin-221 fragment, N-terminal vitronectin) rather than the whole Matrigel mixture, the invention achieves consistent differentiation efficiency across different production lots and manufacturers.
Solution Approach 2:
The invention creates a simplified copy of Matrigel's essential function using purified laminin-221 fragment and N-terminal vitronectin. This copy maintains the biological activity needed for endothelial cell differentiation while eliminating the variability inherent in the original Matrigel product from different manufacturers and lots.
3Ease of manufacture
If Matrigel is used for coating, then the coating can be applied, but complicated manipulations are required and reproducibility is difficult to maintain
Solution Approach 1:
The patent extracts the essential coating function from the complex Matrigel system to specific proteins that can be applied more simply. By using purified laminin-221 fragment and N-terminal vitronectin, the coating process becomes less manipulative-intensive while maintaining reproducibility.
Solution Approach 2:
The invention changes the physical and chemical parameters of the coating material from temperature-sensitive Matrigel to stable purified proteins. This parameter change simplifies the coating application process and improves reproducibility by eliminating temperature-dependent solidification and manufacturer variability.
Data Source
AI summary
Provided is a technology allowing for stable supply of brain microvascular endothelium-like cells. This coating agent for inducing differentiation of pluripotent stem cells into brain microvascular endothelium-like cells contains at least one component of a Laminin-221 fragment or an N-terminal Vitronectin.